Understand Current and Future use of Intensity-Modulated Radiation Therapy.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c89974) has announced the addition of "Radiation Oncology radiation oncology n. The branch of radiology that deals with the use of ionizing radiation to treat cancers. radiation oncology Equipment Assessment: A Survey of Twenty-Seven US-based Radiation Oncologists" to their offering. Deliverable: Survey with key findings Study Description Topic - Radiation Oncology Equipment Assessment Respondent Type - Physicians Specialties Covered - US-based radiation oncologists Region - United States Only Methodology - Online survey, self-administered via a Panel Intelligence website - Duration: 30 minutes - Size: 27 respondents Objectives: To understand current and future use of intensity-modulated radiation therapy intensity-modulated radiation therapy See IMRT. (IMRT IMRT Intensity-modulated radiation therapy Radiation oncology A format for delivering high-dose RT to regions–eg, nasopharynx, that are surrounded by radiation-sensitive areas; in IMRT, a broad radiation field is divided into hundreds of small pencil beams, ), image-guided radiation therapy Image-guided radiation therapy (IGRT) is the process of frequent two and three-dimensional imaging, during a course of radiation treatment, used to direct radiation therapy utilizing the imaging coordinates of the actual radiation treatment plan. (IGRT IGRT Image Guided Radiation Therapy ), stereotactic radiosurgery, adaptive radiotherapy, and proton therapy. - Evaluate the market outlook for several manufacturers including Accuray, Elekta, Siemens Medical, TomoTherapy, and Varian Medical. - Determine drivers of growth for intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery, and adaptive radiotherapy. - Examine the purchasing decision criteria for Varian's new product line including VMAT VMAT Veterinary Medical Assistance Team (National Disaster Medical System) VMAT vesicular monoamine transporter (genetics) VMAT Volumetric Modulated Arc Therapy and DART[TM]. - Assess the outlook for proton therapy. Inclusion Criteria and Respondent Demographics - US-based - Board-certified or board-eligible in specialty - 2 to 30 years of experience post-training - Minimum of 50% professional time spent in clinical practice - Familiar with manufacturers and products For more information visit http://www.researchandmarkets.com/reports/c89974. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion